We Deliver.
NanoStar Pharmaceuticals
NanoStar is a biotech company on a mission to develop safe and innovative drugs that can effectively treat diseases with limited treatment options. Using state-of-the-art engineering technologies, we’re focused on creating novel therapies and overcoming drug delivery challenges to make a meaningful impact on patients’ lives. Our goal is to revolutionize medicine and improve health outcomes worldwide. We’re proud to be at the forefront of drug delivery technology and committed to making a positive difference for patients everywhere.
Unmet Needs
Various unfavorable properties exhibited by investigational drugs, such as poor solubility, low permeability, poor stability, and undesirable pharmacokinetics, can hinder the development of novel therapies. These limitations compromise the bioavailability, efficacy, and therapeutic potential of these agents, making it challenging to achieve the desired pharmacological effects.
However, drug delivery technologies, such as lipid nanoparticles (LNP), offer a promising approach to overcome these challenges by facilitating targeted delivery of investigational drugs to specific cells and tissues. This enhanced targeted delivery improves therapeutic efficacy, promotes desired pharmacological effects, and advances the field of medicine.